Preparation and evaluation of insulin-loaded nanoparticles based on hydroxypropyl-β-cyclodextrin modified carboxymethyl chitosan for oral delivery

Abstract

Novel insulin-loaded nanoparticles based on hydroxypropyl-β-cyclodextrin modified carboxymethyl chitosan (CMC-HP-β-CD) were prepared to improve the oral bioavailability of insulin. The CMC-HP-β-CD was characterized by FT-IR spectroscopy and ¹H-NMR spectra. The insulin-loaded nanoparticles were prepared through crosslinking with calcium ions, and the morphology and size of the prepared nanoparticles were characterized by transmission electron microscopy (TEM) and dynamic light scattering (DLS). Cumulative release in vitro study was performed respectively in simulated gastric medium fluid (SGF, pH=1.2), simulated intestinal fluid (SIF, pH=6.8) and simulated colonic fluid (SCF, pH=7.4). The encapsulation efficiency of insulin was up to 87.14 ± 4.32% through high-performance liquid chromatography (HPLC). Statistics indicated that only 15% of the encapsulated insulin was released from the CMC-HP-β-CD nanoparticles in 36 h in SGF, and about 50% of the insulin could be released from the nanoparticles in SIF, whereas more than 80% was released in SCF. In addition, the solution containing insulin nanoparticles could effectively reduce the blood glucose level of diabetic mice. The cytotoxicity test showed that the samples had no cytotoxicity. CMC-HP-β-CD nanoparticles are promising candidates as potential carriers in oral insulin delivery systems.

Keywords

carboxymethyl chitosan / hydroxypropyl-β-cyclodextrin / nanoparticles / insulin / oral delivery / bioavailability / cytotoxicity

References

[1] Mansourpour M, Mahjub R, Amini M, et al. Development of Acidresistant Alginate/Trimethyl Chitosan Nanoparticles Containing Cationic β-cyclodextrin Polymers for Insulin Oral Delivery[J]. Aaps Pharmscitech., 2015, 16(4): 952-962.

[2] De Araújo TM, Teixeira Z, Barbosa-Sampaio HC, et al. Insulin-loaded poly(ε-caprolactone) Nanoparticles: Efficient, Sustained and Safe Insulin Delivery System[J]. J. Biomed. Nanotechnol., 2013, 9(6): 1098-1106.

[3] Azevedo JR, Sizilio RH, Brito MB, et al. Physical and Chemical Characterization Insulin-loaded Chitosan-TPP Nanoparticles[J]. J. Therm. Anal. Calorim., 2011, 106(3): 685-689.

[4] Zhang X, Sun M, Zheng A, et al. Preparation and Characterization of Insulin-loaded Bioadhesive PLGA Nanoparticles for Oral Administration[J]. Eur. J. Pharm. Sci., 2012, 45(5): 632-638.

[5] Al-Qadi S, Grenha A, Carrión-Recio D, et al. Microencapsulated Chitosan Nanoparticles for Pulmonary Protein Delivery: In vivo evaluation of Insulin-loaded Formulations[J]. J. Control. Release., 2012, 157(3): 383-390.

[6] Santander-Ortega MJ, Bastos-Gonzalez D, Ortega-Vinuesa JL, et al. Insulin-loaded PLGA Nanoparticles for Oral Administration: An in vitro Physico-chemical Characterization[J]. J. Biomed. Nanotechnol., 2009, 5(1): 45-53.

[7] Sarmento B, Ribeiro AJ, Veiga F, et al. Insulin-loaded Nanoparticles are Prepared by Alginate Ionotropic Pre-gelation Followed by Chitosan Polyelectrolyte Complexation[J]. J. Nanosci. Nanotechno., 2007, 7(8): 2833-2841.

[8] Cui F, Qian F, Zhao Z, et al. Preparation, Characterization, and Oral Delivery of Insulin Loaded Carboxylated Chitosan Grafted poly(Methyl Methacrylate) Nanoparticles[J]. Biomacromolecules., 2009, 10(5): 1253-1258.

[9] Cheng G, Liu T, Dang Y, et al. pH/redox Responsive Core Cross-Linked Nanoparticles from Thiolated Carboxymethyl Chitosan for in Vitro Release study of Methotrexate[J]. Carbohyd Polym., 2014, 111(20): 964-970.

[10] Giovino C, Ayensu I, Tetteh J, et al. Development and Characterisation of Chitosan Films Impregnated with Insulin Loaded PEG-b-PLA Nanoparticles (NPs): A Potential Approach for Buccal Delivery of Macromolecules[J]. Int. J. Pharm., 2012, 428(1/2): 143-151.

[11] Gerweck LE, Seetharaman K. Cellular pH Gradient in Tumor Versus Normal Tissue: Potential Exploitation for the Treatment of Cancer[J]. Cancer. Res., 1996, 56(6): 1194-1198.

[12] Liu C, Fan W, Chen X, et al. Self-assembled Nanoparticles Based on Linoleic-acid Modified Carboxymethyl-chitosan as Carrier of Adriamycin (ADR)[J]. Curr. Appl. Phys., 2007, 7: 125-129.

[13] Yang J, Sun H, Song C. Preparation, Characterization and in Vivo Evaluation of pH-sensitive Oral Insulin-loaded poly(lactic-coglycolicacid) Nanoparticles[J]. Diabetes. Obes. Metab., 2012, 14(4): 358-364.

[14] Elsayed A, Al-Remawi M, Maghrabi I, et al. Development of Insulin Loaded Mesoporous Silica Injectable Particles Layered by Chitosan as a Controlled Release Delivery System[J]. Int. J. Pharm., 2014, 461(1/2): 448-458.

[15] Cui FD, Tao AJ, Cun DM, et al. Preparation of Insulin Loaded PLGAHp55 Nanoparticles for Oral Delivery[J]. J. Pharm. Sci., 2007, 96(2): 421-427.

[16] Zhang L, Zhang Z, Na L, et al. Synthesis and Evaluation of a Novel β-cyclodextrin Derivative for Oral Insulin Delivery and Absorption[J]. Int. J. Biol. Macromol., 2013, 61: 494-500.

[17] Kumar PS, Saini TR, Chandrasekar D, et al. Novel Approach for Delivery of Insulin Loaded poly(lactide-co-glycolide) Nanoparticles Using a Combination of Stabilizers[J]. Drug. Deliv., 2007, 14(8): 517-523.

[18] Gould S, Scott R C. 2-Hydroxypropyl-beta-cyclodextrin (HP-β-CD): a Toxicology Review[J]. Food. Chem. Toxicol., 2005, 43(10): 1451-1459.

[19] Tao HQ, Meng Q, Li MH, et al. HP-β-CD-PLGA Nanoparticles Improve the Penetration and Bioavailability of Puerarin and Enhance the Therapeutic Effects on Brain Ischemia-reperfusion Injury in Rats[J]. N-S. Arch. Pharmacol., 2013, 386(1): 61-70.

[20] Zhang X, Zhang X, Gao X, et al. β-Cyclodextrin Grafting Hyperbranched Polyglycerols as Carriers for Nasal Insulin Delivery[J]. Carbohyd Polym., 2011, 84(4): 1419-1425.

[21] Liu M, Wen C, Sun Y, et al. Preparation, Characterization and in vivo Evaluation of Formulation of Repaglinide with Hydroxypropyl-β-cyclodextrin[J]. Int. J. Pharm., 2014, 477(1–2): 159-166.

[22] Zhang L, Zhu W, Lin Q, et al. Hydroxypropyl-β-cyclodextrin Functionalized Calcium Carbonate Microparticles as a Potential Carrier for Enhancing Oral Delivery of Water-insoluble Drugs[J]. Int. J. Nanomed., 2015, 10: 3291-3302.

[23] Dan W, Li H, Gu J, et al. Ternary System of Dihydroartemisinin with Hydroxypropyl-β-cyclodextrin and Lecithin: Simultaneous Enhancement of drug Solubility and Stability in Aqueous Solutions[J]. J. Pharmaceut. Biomed., 2013, 83(83): 141-148.

[24] Zhang L, Zhang Z, Na L, et al. Synthesis and Evaluation of a Novel β-cyclodextrin Derivative for Oral Insulin Delivery and Absorption[J]. Int. J. Biol. Macromol., 2013, 61: 494-500.

[25] Zhang L, Jiang H, Zhu W, et al. Improving the Stability of Insulin Solutions Containing Intestinal Proteases in vitro[J]. Int. J. Mol. Sci., 2008, 9: 2376-2387.

[26] Zhang L, Song L, Zhang C, et al. Improving Intestinal Insulin Absorption Efficiency Through Coadministration of Cell-penetrating Peptide and Hygroxypropyl-β-cyclodextrin[J]. Carbohyd Polym., 2012, 87: 1822-1827.

[27] Aiassa V, Zoppi A, Albesa I, et al. Inclusion Complexes of Chloramphenicol with β -cyclodextrin and Aminoacids as a Way to Increase drug Solubility and Modulate ROS Production[J]. Carbohyd Polym., 2015, 121: 320-327.

[28] Bruno S, Donatella M, Maria C B, et al. Effect of Chitosan Coating in Overcoming the Phagocytosis of Insulin Loaded Solid Lipid Nanoparticles by Mononuclear Phagocyte System[J]. Carbohyd Polym., 2011, 84(3): 919-925.

[29] Lin CC, Lin CW. Preparation of N, O-carboxymethyl Chitosan Nanoparticles as an Insulin Carrier[J]. Drug. Deliv., 2009, 16(8): 458-464.

[30] Mayura O, Jagdish S. Chitosan-zinc-insulin Complex Incorporated Thermosensitive Polymerfor Controlled Delivery of Basal Insulin in Vivo[J]. J. Control. Release., 2012, 163: 145-153.

[31] Jin Y, Song YP, Zhu X, et al. Goblet Cell-targeting Nanoparticles for Oral Insulin Delivery and the Influence of Mucus on Insulin Transport[J]. Biomaterials., 2012, 33: 1573-1582.

[32] Wan Y, Wu C, Xiong G, et al. Mechanical Properties and Cytotoxicity of Nanoplate-like Hydroxyapatite/polylactide Nanocomposites Prepared by Intercalation Technique[J]. J. Mech. Behav. Biomed., 2015, 47: 29-37.

[33] He M, Xue J, Geng H, et al. Fibrous Guided Tissue Regeneration Membrane Loaded with Anti-inflammatory Agent Prepared by Coaxial Electrospinning for the Purpose of Controlled Release[J]. Appl. Surf. Sci., 2015, 335: 121-129.

[34] Zhan J, Tian X, Zhu Y, et al. Oxygen Plasma Modified P(3HB-4HB) Used as Anticoagulant Materials[J]. Appl. Surf. Sci., 2013, 280(9): 564-571.

[35] Anitha A, Divya Rani VV, Krishna R, et al. Synthesis, Characterization, Cytotoxicity and Antibacterial Studies of Chitosan, O-carboxymethyl and N.O-carboxymethyl Chitosan Nanoparticles[J]. Carbohyd Polym., 2009, 78(4): 672-677.

[36] Xu ZP, Walker TL, Liu K, et al. Layered Double Hydroxide Nanoparticles as Cellular Delivery Vectors of Supercoiled Plasmid DNA [J]. Int. J. Nanomed., 2007, 2: 163-174.